ANGPTL4 and hepatocellular carcinoma: At baseline, significant differences were observed in the plasma levels of sTNFRII (P = 0.002), ANGPTL4 (P = 0.024), sgp130 (P = 0.002), and sEGFR (P = 0.013) amongst Child Pugh 5, 6, and 7 HCC patients (Fig. 1).